Prime Medicine Inc. (PRME) Social Stream
PRIME MEDICINE INC (PRME) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRIME MEDICINE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-15 | 4 | $27 | $22 | $24.25 | $8.98 | 170.04% |
| 2023-04-12 | 5 | $27 | $21 | $23.75 | $8.98 | 164.48% |
| 2023-05-19 | 5 | $27 | $18 | $22.6 | $8.98 | 151.67% |
| 2023-08-07 | 6 | $27 | $18 | $22.833 | $8.98 | 154.27% |
| 2023-08-11 | 6 | $27 | $18 | $22.5 | $8.98 | 150.56% |
| 2023-10-09 | 7 | $27 | $18 | $22 | $8.98 | 144.99% |
| 2023-11-06 | 7 | $27 | $18 | $21.428 | $8.98 | 138.62% |
| 2023-11-07 | 7 | $26 | $18 | $21.285 | $8.98 | 137.03% |
| 2023-12-12 | 8 | $26 | $10 | $19.125 | $8.98 | 112.97% |
| NA | 4 | $NA | $NA | $NA | $8.98 | NA% |
The Trend in the Analyst Price Target
Over the past 134 days, PRME's average price target has gone down $2.4.
Over the past 46 weeks, PRME's average upside potential has been 109.5%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-13 | 4 | 27 | 21 | 23.750 | 14.18 | 67.49% |
| 2023-11-06 | 7 | 27 | 18 | 21.714 | 7.76 | 179.82% |
| 2023-12-12 | 7 | 26 | 12 | 20.428 | 7.57 | 169.85% |
| 2023-12-12 | 7 | 26 | 10 | 19.125 | 7.57 | 152.64% |
| 2023-12-12 | 8 | 26 | 12 | 20.428 | 7.57 | 169.85% |
PRME Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.75 | 5 | 0 | 3 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 61 days, PRME's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PRIME MEDICINE INC's upside potential (average analyst target price relative to current price) is greater than 1094.38% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, PRIME MEDICINE INC's number of analysts covering the stock is higher than 385.23% of them.
- In the context of all US stocks, PRIME MEDICINE INC's average analyst price target is higher than 360.12% of them.
- PRME has a lower variance in analysts' estimates than -240.09% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PRIME MEDICINE INC are ACHV, OCX, and ABIO.
View All Top Stocks by Price Target
Is PRME a Buy, Hold or Sell? See the POWR Ratings now!